Publications by authors named "B Galeano-Bilbao"
This review, conducted by the Andalusian Epilepsy Society, provides an update on recent advances in the treatment of drug-resistant epilepsy, focusing on three new anti-seizure drugs: cenobamate, fenfluramine and cannabidiol. These emerging drugs offer new therapeutic alternatives for patients with drug-resistant focal epilepsy, Dravet syndrome, and Lennox-Gastaut syndrome. The primary objective of this review is to provide healthcare professionals with an up-to-date overview of the efficacy, safety and potential clinical applications of these treatments, backed by the latest evidence.
View Article and Find Full Text PDFArticle Synopsis
- Neurologic impairment can last for months after severe COVID-19 infection due to ongoing inflammation.
- A study analyzed cognitive functions in 152 patients recovering from severe SARS-CoV-2 infection, finding significant issues with memory, executive functions, and attention, alongside elevated anxiety and depression rates.
- The study also identified increased levels of certain plasma biomarkers in these patients, raising concerns about potential long-term cognitive effects or the risk of neurodegenerative diseases.